CompoAtlas

MOBILIZE ESSENCE FORMULA

Natural health product licensed in Canada

Other names
Fu Ren Bu Yin Pian
Licence holder
Eastern Currents Ltd.
NPN or DIN-HM
80044739
Status
Active licence
Licence date
16 September 2013
Revision date
Not provided
Form
Comprimé
Route of administration
Orale
Application type
Traditionnelle

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Cuscuta chinensis

Source : Graine(s)

Extract : Décoction

Extraction ratio : 7.5:1

Dry plant equivalent : 405 mg

54 mgNot calculated
Paeonia lactiflora

Source : Racine

Extract : Décoction

Extraction ratio : 7.5:1

Dry plant equivalent : 360 mg

48 mgNot calculated
Carthamus tinctorius

Source : Fleur

Extract : Décoction

Extraction ratio : 7.5:1

Dry plant equivalent : 225 mg

30 mgNot calculated
Dipsacus japonicus

Source : Racine

Extract : Décoction

Extraction ratio : 7.5:1

Dry plant equivalent : 405 mg

54 mgNot calculated
Albizia julibrissin

Source : Écorce (tige)

Extract : Décoction

Extraction ratio : 7.5:1

Dry plant equivalent : 540 mg

72 mgNot calculated

Non-medicinal ingredients

Stéarate de magnésium, Cellulose

PopulationAgeQuantity per servingFrequency
AdultesNot specified2 Comprimé3 days

Uses authorised in Canada

Combination of Traditional Chinese Medicine Ingredients.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Source

Official Health Canada record, licence 80044739

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line